Whats the Consensus on Cardiorenal Protection for CKD in T2D?
Host: Tessa Laubscher, MBChB, CCFP, FCFP
\n\n Guest: George L. Bakris, MD, FAHA, FASN
\n\n Guest: Mikhail Kosiborod, MD
\n\n\n \n
Managing chronic kidney disease (CKD) and type 2 diabetes (T2D) with multiple medications has become a challenge, and a multidisciplinary approach is needed to achieve optimal cardiorenal outcomes. Join Drs. George Bakris, Mikhail Kosiborod, and Tessa Laubscher as they discuss initiating consensus-based nonsteroidal MRA therapy in their patients with CKD and T2D.